Novel pathogenic GATA6 variant associated with congenital heart disease, diabetes mellitus and necrotizing

Jun Yasuhara1,2, Sathiya N Manivannan1,2, Uddalak Majumdar1,2

  • 1Center for Cardiovascular Research, Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, OH, USA.

Pediatric Research
|September 12, 2023
PubMed

Insights

A novel GATA6 gene variant causes congenital heart disease, diabetes, and necrotizing enterocolitis. This discovery expands the known GATA6 gene mutation spectrum to include intestinal abnormalities.

Area of Science:

  • Genetics and Molecular Biology
  • Developmental Biology
  • Medical Genetics

Background:

  • Pathogenic GATA6 variants are linked to congenital heart disease (CHD) and various extracardiac issues.
  • A complete understanding of GATA6 genotype-phenotype correlations in humans is still developing.

Purpose of the Study:

  • To investigate a family with multiple members affected by CHD.
  • To identify the genetic basis of CHD and associated abnormalities in the studied family.
  • To characterize the functional impact of a novel GATA6 variant.

Main Methods:

  • Whole exome sequencing was utilized to analyze affected family members with CHD.
  • In vitro functional studies, including immunofluorescence, western blot, and dual-luciferase reporter assays, were performed.
  • The identified GATA6 variant's effect on protein localization and transcriptional activity was assessed.

Main Results:

  • A novel heterozygous GATA6 missense variant (p.Cys468Tyr) was identified and segregated with CHD in the family.
  • Affected individuals exhibited persistent truncus arteriosus, diabetes mellitus, and necrotizing enterocolitis with intestinal perforation.
  • Functional assays revealed abnormal nuclear localization, protein aggregation, and reduced transcriptional activity of the mutant GATA6 protein.

Conclusions:

  • A novel familial GATA6 variant (p.Cys468Tyr) is associated with CHD, diabetes mellitus, and necrotizing enterocolitis.
  • This study expands the phenotypic spectrum of pathogenic GATA6 variation to include intestinal abnormalities.
  • Neonatal intestinal perforation is identified as a novel extracardiac phenotype linked to GATA6 mutations.
Abstract

Related Concept Videos

Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
22.9K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.1K
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
4.3K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
16
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
185
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
275